August 2025 in “European Journal of Dermatology” This study found that patients with telogen effluvium experienced higher stress, depression, anxiety, and lower quality of life compared to healthy controls.
June 2025 in “Public Health of Indonesia” This study found that women with chronic telogen effluvium had significantly lower levels of zinc, calcium, vitamin D, and ferritin compared to healthy women without hair loss, suggesting that monitoring and restoring these micronutrients may be crucial in managing this condition.
December 2024 in “Aesthetic Plastic Surgery” In this observational study, patients with androgenic alopecia or hair loss related to COVID-19 showed more significant hair regrowth when treated with combined pulsed electromagnetic field therapy and photobiostimulation therapy compared to photobiostimulation therapy alone, with a statistically significant increase in hair count.
October 2024 in “Archives of Dermatological Research” The study found that patients with androgenetic alopecia had higher serum GPER-1 levels, which were associated with disease severity and duration, indicating a potential estrogen-independent role of GPER-1 in the condition's pathogenesis.
June 2021 in “Egyptian Journal of Dermatology and Venereology” This study found that psoriasis, acne, and androgenetic alopecia are associated with an atherogenic lipid profile, suggesting an increased risk of atherosclerosis and cardiovascular disease, especially among psoriasis patients.
March 2010 in “The Journal of Urology” This study found that men with early-onset androgenetic alopecia had larger prostate volumes and lower urinary flow rates compared to those without the condition, suggesting a potential link between AGA and urinary symptoms.
Low level laser or LED therapy combined with infiltrations may help hair growth.
October 2023 in “Journal of the Endocrine Society” In this case report, a 21-year-old woman with PCOS and obesity underwent bariatric surgery, leading to significant weight loss and improved hormonal balance, which alleviated her hyperandrogenism symptoms like hirsutism and irregular periods.
October 2023 in “Journal of the Endocrine Society” In this case study, the authors observed that weight loss coupled with a brief use of oral contraceptives was associated with normalized testosterone levels in a woman with severe hyperandrogenism and PCOS.
April 2012 in “The Journal of Urology” This case-control study found that men with earlier onset androgenetic alopecia, particularly frontal balding, may have an increased risk of prostate cancer in a multiethnic veterans cohort.
August 2024 in “Journal of Dermatology & Cosmetology” This case study reports a patient with Rothmund-Thomson syndrome manifesting later in life, who was treated with acitretin to prevent non-melanoma skin cancer associated with the condition.
3 citations
,
July 2022 in “BJOG: An International Journal of Obstetrics and Gynaecology” This study reports that among young women, combined oral contraceptives containing chlormadinone, among others, are associated with an increased risk of venous thromboembolism compared to those containing levonorgestrel with low ethinylestradiol.
12 citations
,
March 2013 in “Cancer Causes & Control” This study found that an earlier onset of androgenetic alopecia, especially in a frontal balding pattern, was significantly associated with an increased risk of prostate cancer among men at a Veterans Affairs Hospital.
March 2026 in “Clinical Cosmetic and Investigational Dermatology” In this case study, treatment with the selective JAK1 inhibitor upadacitinib significantly improved symptoms in a patient with refractory alopecia areata, vitiligo, ankylosing spondylitis, and allergic asthma-nasal syndrome, though a transient liver function abnormality was noted.
1 citations
,
January 2017 in “Indian Journal of Pharmaceutical Sciences” This study found that women with polycystic ovary syndrome in South India had higher body mass index, waist/hip ratio, and elevated levels of several hormones compared to controls, and waist/hip ratio may be a better risk indicator than body mass index.
January 2024 in “The Egyptian Journal of Hospital Medicine (Print)” This study found that there was no statistically significant difference in serum zinc levels between patients with pattern hair loss and healthy controls, and concluded that zinc deficiency is unlikely to be a direct cause of androgenetic alopecia.
1 citations
,
October 2014 in “Skin Pharmacology and Physiology” This study found that osteopontin expression was significantly higher in alopecia areata lesions compared to healthy controls, suggesting it may play a role in the disease's pathogenesis.
June 1995 in “International Journal of Gynecology & Obstetrics” Long-term use of oral contraceptives, especially starting before age 20, may increase the risk of early-onset breast cancer.
1 citations
,
December 2014 in “Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology” This study reports that a 15-year-old with trichotillomania showed improvement with aripiprazole treatment, though no consensus on treatment exists in the literature.
This case study reports significant clinical and hormonal improvement in a 21-year-old woman with HAIR-AN syndrome after nine months of treatment with oral contraceptives and spironolactone.
January 2022 in “Acta Scientific Women's Health” This autobiographical case study describes a 25-year-old woman with PCOS who successfully managed her symptoms using hormonal therapy, including oral contraceptives and Myo-Inositol, leading to normalized menstrual cycles and the resolution of most symptoms.
40 citations
,
June 2013 in “Scientific Reports” This study found an association between a splice site variant in the KRT71 gene and curly hair in Selkirk Rex cats, identifying a significant locus on chromosome B4.
1 citations
,
January 2021 in “Wiadomości Lekarskie” This experimental study on male rats found that a gel containing carbon dioxide extract of hops effectively promoted wound healing in severe acne by enhancing skin regeneration and exhibiting anti-inflammatory, bactericidal, and antimycotic properties.
5 citations
,
January 2021 in “Journal of Cosmetic Dermatology” This study found that topical cetirizine treatment significantly improved hair regrowth and patient satisfaction in male patients with androgenetic alopecia compared to a placebo, highlighting its potential role in treatment.
June 2025 in “Revista Brasileira de Fisioterapia Pelvica” In this case report, four sessions of the Broad Ligament Maneuver were associated with improvements in ovarian function and regression of PCOS symptoms, including normalizing menstrual flow and decreasing hirsutism.
March 2024 in “The journal of sexual medicine” This case study observed that in four middle-aged men with ejaculation disorders, therapy with human chorionic gonadotropin (hCG) alone or combined with recombinant follicle-stimulating hormone (rFSH) improved sexual desire, semen volume, and various other symptoms, although some experienced elevated estradiol levels and hair loss.
July 2021 in “Journal of emerging technologies and innovative research” This article discusses Ayurvedic perspectives on acne vulgaris and outlines potential natural remedies, but it presents no new clinical findings.
September 2022 in “Translational Andrology and Urology” This study found that in young men with post-finasteride syndrome, there are potential genetic risk factors associated with psychological and sexual dysfunctions, suggesting genetic screening may be beneficial before prescribing finasteride.
1 citations
,
September 2024 in “Life” This study reports three cases of alopecia areata resistant to corticosteroids that improved after 16 weeks of treatment with a combination of fractional carbon dioxide laser and topical tacrolimus, suggesting a potential new therapeutic option that requires further confirmation.
December 2025 in “International Journal for Fundamental and Interdisciplinary Research in Homoeopathy.” In this retrospective case series, researchers observed that a combined treatment protocol of homoeopathy, Xogen therapy, diet, and vitamin supplementation progressively reduced hair fall and improved hair density in five male patients with androgenic alopecia.